Delivery Order SPE2DB24D2003-SPE2DB25FXMC3
- Not listed
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,176.72 for Mounjaro 10 mg/0.5 ml pen (0.5ml) on July 29, 2025, with an ultimate completion date of July 30, 2025. This firm fixed price, non-set-aside contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a single transaction for this diabetes medication under a larger contract vehicle. This award is a child delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,607.06 to AmerisourceBergen Drug Corp for Mounjaro 7.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. This competitively awarded, firm fixed price contract was executed on July 24, 2025, with an ultimate completion date of July 25, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,601.07 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen (0.5 mL), a diabetes treatment medication. The contract is structured as a firm fixed price delivery order with an ultimate completion date of September 22, 2025. This award was made on a competitive basis with no set-aside designation, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,360.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 2.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract, awarded on May 6, 2025, with an ultimate completion date of May 7, 2025, was competitively awarded without a set-aside designation under firm fixed-price terms. Performance will take place at the company's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,360.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 7.5 mg/0.5 ml pen (0.5 ml), a diabetes medication. The contract was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and is classified as a firm fixed price delivery order with no set-aside designation. Performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a $5,843.98 delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Mounjaro 15 mg/0.5 mL pens (0.5 mL quantity). This firm fixed price delivery order, with an ultimate completion date of August 21, 2025, represents a pediatric/adult diabetes medication procurement supporting military healthcare operations. The contract utilizes no set-aside designation and was competitively awarded through open procurement, with performance...
- The Defense Logistics Agency awarded a delivery order valued at $1,631.78 to AmerisourceBergen Drug Corp for Mounjaro 12.5 mg/0.5 mL pen (0.5 mL), a diabetes medication. The award was made on July 28, 2025, with an ultimate completion date of July 29, 2025, under a firm fixed-price contract type with no set-aside designation. The product will be performed and delivered from AmerisourceBergen's location in Conshohocken, Pennsylvania, the company's corporate headquarters. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $1,952.86 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 mL pens on August 28, 2025, with an ultimate completion date of August 29, 2025. This is a firm fixed price, non-set-aside delivery order for the diabetes medication, to be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order valued at $1,360.45 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pens (0.5 ml units), a diabetes medication. The contract was awarded on April 21, 2025, with an ultimate completion date of April 22, 2025, and utilized firm fixed price pricing with no set-aside designation. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order valued at $1,267.45 to AmerisourceBergen Drug Corp for Mounjaro 10 mg/0.5 mL pen (0.5 mL), a diabetes medication. The contract is firm fixed price with no set-aside designation and carries an ultimate completion date of April 28, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DB24D2003Indefinite Delivery Contract
- SPE2DB24D2003-SPE2DB25FXMC3Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,249.48 to AmerisourceBergen Drug Corp for the supply of Mounjaro 5 mg/0.5 ml pen (0.5ml), a diabetes medication. The contract, awarded on August 26, 2025, with an ultimate completion date of August 27, 2025, was competitively awarded with no set-aside designation and employs firm fixed-price pricing. Performance will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive portfolio of pharmaceutical products and medical supplies to support military and veteran healthcare systems. The prime indefinite delivery vehicle serves as a global pharmaceutical support mechanism enabling the company to fulfill federal medical supply requirements across multiple therapeutic domains for customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 8/26/25 |